Rick Doblin

0:02:19

Breakthrough for Psychedelic Medicine - Rick Doblin, Ph.D.

0:01:09

Rick Doblin: MDMA for PTSD

0:36:23

PSYCH Investor Summit: Research & Development - Rick Doblin Keynote Address

0:51:03

Psychedelic Therapy & Research Movement - Rick Doblin, Ph.D. | The FitMind Podcast

0:01:59

What Psychedelics Do | Rick Doblin

0:45:37

Psychedelic Mystical Experiences, Social Change & Therapeutic Outcomes - Rick Doblin

0:02:20

Rick Doblin's Vision For The Future Of Psychedelic Therapies

0:00:35

PSYCH Interview: Rick Doblin - Market Sizing and Health Care Coverage

0:02:30

PSYCH Interview: Rick Doblin - Patents vs. Data Exclusivity

0:01:26

PSYCH Interview: Rick Doblin - Licensed Psychedelic Legalization by 2035

0:15:07

Rick Doblin Debunks Myths and Details Breakthroughs in MDMA Research

0:03:01

PSYCH Interview: Rick Doblin - Science and Stories, the Keys to Shifting Cultural Attitudes

0:11:59

Rick Doblin, Ph.D. of MAPS with Dr. Henrik Jungaberle | INSIGHT 2021

0:01:09

PSYCH Interview: Rick Doblin - Groundbreaking Phase 3 Study Results for PTSD with MDMA

0:35:23

Rick Doblin: Regulatory challenges involved in developing psychedelic- assisted psychotherapy

0:00:35

CannMed Reactions - Rick Doblin

0:02:16

PSYCH Interview: Rick Doblin - Ensuring a Supply Chain of Trained Psychedelic Therapists

0:31:54

Breakthrough new study on effectiveness of MDMA | Rick Doblin and Lex Fridman

0:07:49

Differences between psychedelic drugs | Rick Doblin and Lex Fridman

0:08:33

Where Psychedelic Medicines Are Headed with Rick Doblin, PhD - MAPS

0:00:50

PSYCH Interview: Rick Doblin - Is Telemedicine and the Psychedelic 'Take-Home' Method Effective?

1:30:02

Spirituality & Psychedelics with Rick Doblin

0:01:35

MDMA-Assisted Psychotherapy for Veterans with PTSD - Rick Doblin, Ph.D.

0:03:37

Introduction to Psychedelics | Rick Doblin and Lex Fridman